Cefoxitin-Serum Creatinine Interference in a Patient With Nontuberculous
Document Type
Article
Publication Date
8-2021
Publication Title
Journal of pharmacy practice
Abstract
Cefoxitin is a second-generation cephamycin antibiotic, which at concentrations ≥100 µg/mL is known to modestly interfere, for up to 2 hours post-infusion, with serum creatinine measurement via the traditional Jaffe-based assay. We report a case of a severe serum creatinine elevation while utilizing cefoxitin as a component of an antimicrobial regimen in a critically ill patient with
Volume
34
Issue
4
First Page
658
Last Page
661
Recommended Citation
Wang D, Emanuel AJ, Neyens RR, Bakharev E, Babic N. Cefoxitin-Serum Creatinine Interference in a Patient With Nontuberculous Mycobacteria Ventriculomeningitis. J Pharm Pract. 2021 Aug;34(4):658-661. doi: 10.1177/0897190020921613. Epub 2020 Apr 30. PMID: 32351174.
DOI
10.1177/0897190020921613
ISSN
1531-1937
PubMed ID
32351174
COinS